What is Enliven Therapeutics, Inc. Common Stock's Market Cap?

Enliven Therapeutics, Inc. Common Stock's Market Cap is $4.3B, based on as-reported figures from SEC (XBRL) filings.

What is Enliven Therapeutics, Inc. Common Stock's Enterprise Value?

Enliven Therapeutics, Inc. Common Stock's Enterprise Value is $3.4B, based on as-reported figures from SEC (XBRL) filings.

What is Enliven Therapeutics, Inc. Common Stock's EV / EBITDA?

Enliven Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Enliven Therapeutics, Inc. Common Stock's Net Income (TTM)?

Enliven Therapeutics, Inc. Common Stock's Net Income (TTM) is -$105.9M, based on as-reported figures from SEC (XBRL) filings.

What is Enliven Therapeutics, Inc. Common Stock's EBITDA?

Enliven Therapeutics, Inc. Common Stock's EBITDA is -$124.2M, based on as-reported figures from SEC (XBRL) filings.

What is Enliven Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Enliven Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.45, based on as-reported figures from SEC (XBRL) filings.

What is Enliven Therapeutics, Inc. Common Stock's Net Debt?

Enliven Therapeutics, Inc. Common Stock's Net Debt is -$895.2M, based on as-reported figures from SEC (XBRL) filings.

Enliven Therapeutics, Inc. Common Stock (ELVN) Financial Statements

Enliven Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00CP3BDF2

XNAS · usd

58.30▼ 1.07 (-1.80%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close59.37

Day's Range58.24 – 59.90

52-Week Range14.79 – 62.32

Volume1.3M

Avg Volume984.8K

Share Statistics

Shares Outstanding

Employees60

ExchangeXNAS

Listed2023-02-24

Share count as of July 28, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Enliven Therapeutics, Inc. Common Stock (ELVN)

What is Enliven Therapeutics, Inc. Common Stock's Market Cap?: Enliven Therapeutics, Inc. Common Stock's Market Cap is $4.3B, based on as-reported figures from SEC (XBRL) filings.
What is Enliven Therapeutics, Inc. Common Stock's Enterprise Value?: Enliven Therapeutics, Inc. Common Stock's Enterprise Value is $3.4B, based on as-reported figures from SEC (XBRL) filings.
What is Enliven Therapeutics, Inc. Common Stock's EV / EBITDA?: Enliven Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Enliven Therapeutics, Inc. Common Stock's Net Income (TTM)?: Enliven Therapeutics, Inc. Common Stock's Net Income (TTM) is -$105.9M, based on as-reported figures from SEC (XBRL) filings.
What is Enliven Therapeutics, Inc. Common Stock's EBITDA?: Enliven Therapeutics, Inc. Common Stock's EBITDA is -$124.2M, based on as-reported figures from SEC (XBRL) filings.
What is Enliven Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Enliven Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.45, based on as-reported figures from SEC (XBRL) filings.
What is Enliven Therapeutics, Inc. Common Stock's Net Debt?: Enliven Therapeutics, Inc. Common Stock's Net Debt is -$895.2M, based on as-reported figures from SEC (XBRL) filings.